In vitro studies with ALK+ NSCLC cells have identified several diverse types of ALK‐TKI–induced DTP cells, including those including those in which YAP‐TEAD, HER3, or glycogen synthase kinase 3 (GSK3) pathways are activated [5, 22, 25, 26]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.